Home/Filings/4/0001181431-12-013877
4//SEC Filing

DUFFEY SAMUEL S 4

Accession 0001181431-12-013877

CIK 0001310094other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 4:37 PM ET

Size

5.4 KB

Accession

0001181431-12-013877

Insider Transaction Report

Form 4
Period: 2012-02-29
DUFFEY SAMUEL S
PRESIDENT AND GENERAL COUNSEL
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-02-29+600,000600,000 total
    Exercise: $0.44From: 2012-02-29Exp: 2022-03-01Common Stock (600,000 underlying)
Footnotes (3)
  • [F1]Exercise price is 100% of fair market value on date of grant.
  • [F2]The options vested immediately on the date of grant.
  • [F3]The options terminate 10 years from the grant date, or 90 days after the employee ceases to be an employee for any reason, other than death, disability or retirement.

Documents

1 file

Issuer

ACCENTIA BIOPHARMACEUTICALS INC

CIK 0001310094

Entity typeother

Related Parties

1
  • filerCIK 0001255259

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:37 PM ET
Size
5.4 KB